Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 1 - 10 of 11 opportunities
Novel compounds displaying high potency and selectivity toward SRC family kinases have been developed. The lead compound eCF506 displays subnanomolar potency against SRC, high selectivity over ABL kinase (1000-fold), optimal pharmacokinetic profile and in vivo target engagement.
This new approach converts chemotherapy agents into prodrugs, significantly reducing systemic toxicity, and enabling local activation only at tumour sites where a specific catalyst, palladium, has been implanted.
The presence of cancer causes changes to the immune system. A 13-gene signature characteristic of the presence of breast cancer has been identified from blood samples, and a diagnostic to identify this signature as a means of detecting breast cancer more effectively than existing methods has been de...
Researchers at the University of Dundee have designed and synthesised a novel, multifunctional protease inhibitor that has the potential to significantly enhance the performance of vaccines through proteolytic modulation.
Researchers at the University of Dundee have developed a robust and original method for interrogating the activity of single bromodomain proteins, which will assist in exploring their role in the epigenetics of health and disease.
Combining the sequential use of 2 enzymes – fluorinase and nucleoside hydrolase – we have successfully produced a new radiotracer with potential as an imaging biomarker for PET scans. The fluorinase enzyme combines fluorine with S-adenosyl-L-methionine (SAM) to generate 5'-fluro-5'-deoxy...
Prostate Cancer, caught early enough, is increasingly treatable. Digital rectal examination of the Prostate is often the first stage of prostate cancer screening but is somewhat subjective. eFinger offers an alternative - a numerical non-subjective indication based on prostate tissue properties to p...
Scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment.
The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.
A tetrazine small-molecule trigger for activating prodrugs has been developed. Active molecules, such as a therapeutic drug or imaging fluorophore, can be caged within a polymer nanoparticle for controlled release at a targeted site.
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities